Mereo BioPharma Group plc (MREO) has 11 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, DAWN, EFTR, ELEV, HEPA and others.
MREO has a market capitalization of $54.08M, compared to an average peer market cap of $815.74M. MREO is notably smaller than its average peer.
